Jeffrey Stevens is the founder and CEO of Physio AI, where he leads development of AI-enabled physiological monitoring, software-defined wearable sensor platforms, and clinical decision-support technologies. An entrepreneur, inventor, and technology executive with more than four decades of experience, he has worked across medical devices, biosensors, data science, enterprise platforms, and product commercialization.

Since 2015, Jeff has focused on human physiological and biological sensing. His work includes winning the 2017 NASA iTech competition for his wireless crew health technology and later developing a hypoxia early-warning prototype for pilots using O2 and CO2 sensors. Earlier in his career, he pioneered AI and large-scale computing applications in financial services and held senior technology roles at Merrill Lynch and Citicorp.

He holds an MBA in Finance from New York University and a BA from UCLA, with coursework spanning business, computer science, physics, and public health.